| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-27 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $696.9M | $625.8M | $460.1M |
| YoY Revenue Growth % | +11.4% | +36.0% | — |
| Gross Profit | — | $534.2M | — |
| Gross Margin % | — | 85.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $179.3M | $165.6M | $112.6M |
| Operating Margin % | 25.7% | 26.5% | 24.5% |
| Net Income (GAAP) | $174.3M | $108.7M | $70.2M |
| EBITDA (Normalized) | $217.2M | $207.2M | $129.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $153.1M | $157.6M | $121.6M |
| Capital Expenditures (CapEx) | $47.4M | $51.9M | $20.7M |
| Free Cash Flow (FCF) | $105.6M | $105.7M | $100.9M |
| FCF Margin % | 15.2% | 16.9% | 21.9% |
| Return on Invested Capital (ROIC %) | 51.4% | 60.9% | 6.8% |
| Cash & Short-Term Equivalents | $196.6M | $315.9M | — |
| Total Debt (Short + Long Term) | $1.21B | $1.21B | $506.2M |
| Total Stockholders' Equity | -$736.8M | -$675.6M | $1.04B |